Retraction notice to “Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer” [Heliyon 9 (2023) e15782]
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-11-01
|
| Series: | Heliyon |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023095828 |
| _version_ | 1797429724392194048 |
|---|---|
| author | Ibrahim A. Darwish Nourah Z. Alzoman Nehal N.Y. Khalil Hany W. Darwish |
| author_facet | Ibrahim A. Darwish Nourah Z. Alzoman Nehal N.Y. Khalil Hany W. Darwish |
| author_sort | Ibrahim A. Darwish |
| collection | DOAJ |
| first_indexed | 2024-03-09T09:17:18Z |
| format | Article |
| id | doaj.art-e4309ac46bfa4530871f9b539b58f98d |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-03-09T09:17:18Z |
| publishDate | 2023-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-e4309ac46bfa4530871f9b539b58f98d2023-12-02T07:05:52ZengElsevierHeliyon2405-84402023-11-01911e22374Retraction notice to “Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer” [Heliyon 9 (2023) e15782]Ibrahim A. Darwish0Nourah Z. Alzoman1Nehal N.Y. Khalil2Hany W. Darwish3Corresponding author.; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi ArabiaDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi ArabiaDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi ArabiaCorresponding author.; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabiahttp://www.sciencedirect.com/science/article/pii/S2405844023095828 |
| spellingShingle | Ibrahim A. Darwish Nourah Z. Alzoman Nehal N.Y. Khalil Hany W. Darwish Retraction notice to “Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer” [Heliyon 9 (2023) e15782] Heliyon |
| title | Retraction notice to “Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer” [Heliyon 9 (2023) e15782] |
| title_full | Retraction notice to “Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer” [Heliyon 9 (2023) e15782] |
| title_fullStr | Retraction notice to “Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer” [Heliyon 9 (2023) e15782] |
| title_full_unstemmed | Retraction notice to “Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer” [Heliyon 9 (2023) e15782] |
| title_short | Retraction notice to “Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer” [Heliyon 9 (2023) e15782] |
| title_sort | retraction notice to development of a highly sensitive chemiluminescence immunoassay using a novel signal enhanced detection system for quantitation of durvalumab an immune checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer heliyon 9 2023 e15782 |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023095828 |
| work_keys_str_mv | AT ibrahimadarwish retractionnoticetodevelopmentofahighlysensitivechemiluminescenceimmunoassayusinganovelsignalenhanceddetectionsystemforquantitationofdurvalumabanimmunecheckpointinhibitormonoclonalantibodyusedforimmunotherapyoflungcancerheliyon92023e15782 AT nourahzalzoman retractionnoticetodevelopmentofahighlysensitivechemiluminescenceimmunoassayusinganovelsignalenhanceddetectionsystemforquantitationofdurvalumabanimmunecheckpointinhibitormonoclonalantibodyusedforimmunotherapyoflungcancerheliyon92023e15782 AT nehalnykhalil retractionnoticetodevelopmentofahighlysensitivechemiluminescenceimmunoassayusinganovelsignalenhanceddetectionsystemforquantitationofdurvalumabanimmunecheckpointinhibitormonoclonalantibodyusedforimmunotherapyoflungcancerheliyon92023e15782 AT hanywdarwish retractionnoticetodevelopmentofahighlysensitivechemiluminescenceimmunoassayusinganovelsignalenhanceddetectionsystemforquantitationofdurvalumabanimmunecheckpointinhibitormonoclonalantibodyusedforimmunotherapyoflungcancerheliyon92023e15782 |